TreeWAS – Variant ID: rs6914704

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I44.7 Left bundle-branch block, unspecified	0.000	0.920	0.080
I51.8 Other ill-defined heart diseases	0.000	0.928	0.072
K26.3 Acute without haemorrhage or perforation	0.000	0.935	0.065
I44.0 Atrioventricular block, first degree	0.000	0.942	0.058
I44 Atrioventricular and left bundle-branch block	0.000	0.943	0.057
I44.5 Left posterior fascicular block	0.000	0.959	0.041
I44.2 Atrioventricular block, complete	0.000	0.960	0.040
I44.3 Other and unspecified atrioventricular block	0.000	0.961	0.039
I44.4 Left anterior fascicular block	0.000	0.962	0.038
I44.6 Other and unspecified fascicular block	0.000	0.965	0.035
H04.5 Stenosis and insufficiency of lachrymal passages	0.035	0.965	0.000
H04.1 Other disorders of lachrymal gland	0.030	0.970	0.000
H04 Disorders of lachrymal system	0.029	0.971	0.000
I44.1 Atrioventricular block, second degree	0.000	0.973	0.027
K26 Duodenal ulcer	0.000	0.975	0.025
K26.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.975	0.025
H04.4 Chronic inflammation of lachrymal passages	0.024	0.976	0.000
H04.0 Dacryoadenitis	0.022	0.978	0.000
H04.9 Disorder of lachrymal system, unspecified	0.021	0.979	0.000
K26.6 Chronic or unspecified with both haemorrhage and perforation	0.000	0.979	0.021
D86.9 Sarcoidosis, unspecified	0.020	0.980	0.000
H04.6 Other changes in lachrymal passages	0.020	0.980	0.000
D86 Sarcoidosis	0.020	0.980	0.000
K26.7 Chronic without haemorrhage or perforation	0.000	0.981	0.019
H04.3 Acute and unspecified inflammation of lachrymal passages	0.019	0.981	0.000
K26.0 Acute with haemorrhage	0.000	0.981	0.019
D80 Immunodeficiency with predominantly antibody defects	0.019	0.981	0.000
D86.8 Sarcoidosis of other and combined sites	0.018	0.982	0.000
H05.2 Exophthalmic conditions	0.018	0.982	0.000
D86.1 Sarcoidosis of lymph nodes	0.018	0.982	0.000
D80-D89 Certain disorders involving the immune mechanism	0.017	0.983	0.000
H04.8 Other disorders of lachrymal system	0.017	0.983	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.017	0.983	0.000
H05 Disorders of orbit	0.017	0.983	0.000
D80.1 Nonfamilial hypogammaglobulinaemia	0.016	0.984	0.000
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.016	0.984	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.016	0.984	0.000
K26.1 Acute with perforation	0.000	0.984	0.016
I51 Complications and ill-defined descriptions of heart disease	0.000	0.985	0.015
D80.8 Other immunodeficiencies with predominantly antibody defects	0.015	0.985	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.015	0.985	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.015	0.985	0.000
D86.3 Sarcoidosis of skin	0.015	0.985	0.000
K26.2 Acute with both haemorrhage and perforation	0.000	0.985	0.014
J35.0 Chronic tonsillitis	0.000	0.985	0.015
H01 Other inflammation of eyelid	0.014	0.986	0.000
D86.0 Sarcoidosis of lung	0.014	0.986	0.000
I51.3 Intracardiac thrombosis, not elsewhere classified	0.000	0.986	0.014
D80.7 Transient hypogammaglobulinaemia of infancy	0.014	0.986	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.014	0.986	0.000
D80.0 Hereditary hypogammaglobulinaemia	0.014	0.986	0.000
D84 Other immunodeficiencies	0.013	0.987	0.000
H01.9 Inflammation of eyelid, unspecified	0.013	0.987	0.000
H05.4 Enophthalmos	0.013	0.987	0.000
D83 Common variable immunodeficiency	0.013	0.987	0.000
D81 Combined immunodeficiencies	0.013	0.987	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.013	0.987	0.000
H05.0 Acute inflammation of orbit	0.013	0.987	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.013	0.987	0.000
H06 Disorders of lachrymal system and orbit in diseases classified elsewhere	0.012	0.987	0.000
H05.3 Deformity of orbit	0.012	0.988	0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.012	0.988	0.000
H05.5 Retained (old) foreign body following penetrating wound of orbit	0.012	0.988	0.000
I51.5 Myocardial degeneration	0.000	0.988	0.012
H05.9 Disorder of orbit, unspecified	0.012	0.988	0.000
H05.1 Chronic inflammatory disorders of orbit	0.012	0.988	0.000
I51.7 Cardiomegaly	0.000	0.988	0.012
H02.1 Ectropion of eyelid	0.012	0.988	0.000
I51.1 Rupture of chordae tendineae, not elsewhere classified	0.000	0.988	0.012
H03 Disorders of eyelid in diseases classified elsewhere	0.011	0.988	0.000
I51.2 Rupture of papillary muscle, not elsewhere classified	0.000	0.989	0.011
D82 Immunodeficiency associated with other major defects	0.011	0.989	0.000
H01.1 Non-infectious dermatoses of eyelid	0.011	0.989	0.000
K26.5 Chronic or unspecified with perforation	0.000	0.989	0.011
D04.7 Skin of lower limb, including hip	0.000	0.989	0.011
D89.9 Disorder involving the immune mechanism, unspecified	0.011	0.989	0.000
I51.6 Cardiovascular disease, unspecified	0.000	0.989	0.011
D84.9 Immunodeficiency, unspecified	0.010	0.990	0.000
D84.1 Defects in the complement system	0.010	0.990	0.000
J93.1 Other spontaneous pneumothorax	0.010	0.990	0.000
D89.1 Cryoglobulinaemia	0.010	0.990	0.000
D04 Carcinoma in situ of skin	0.000	0.990	0.010
H01.8 Other specified inflammation of eyelid	0.010	0.990	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.010	0.990	0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.010	0.990	0.000
H06.2 Dysthyroid exophthalmos	0.010	0.990	0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.010	0.990	0.000
D83.9 Common variable immunodeficiency, unspecified	0.009	0.991	0.000
D83.8 Other common variable immunodeficiencies	0.009	0.991	0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.009	0.991	0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.009	0.991	0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.009	0.991	0.000
D81.9 Combined immunodeficiency, unspecified	0.009	0.991	0.000
D81.8 Other combined immunodeficiencies	0.009	0.991	0.000
D81.7 Major histocompatibility complex class II deficiency	0.009	0.991	0.000
D81.6 Major histocompatibility complex class I deficiency	0.009	0.991	0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.009	0.991	0.000
D81.4 Nezelof's syndrome	0.009	0.991	0.000
D81.3 Adenosine deaminase [ADA] deficiency	0.009	0.991	0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.009	0.991	0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.009	0.991	0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.009	0.991	0.000
D89.3 Immune reconstitution syndrome	0.009	0.991	0.000
H06.3 Other disorders of orbit in diseases classified elsewhere	0.009	0.991	0.000
H06.1 Parasitic infestation of orbit in diseases classified elsewhere	0.009	0.991	0.000
H06.0 Disorders of lachrymal system in diseases classified elsewhere	0.009	0.991	0.000
D04.9 Skin, unspecified	0.000	0.991	0.009
D04.3 Skin of other and unspecified parts of face	0.000	0.991	0.009
H05.8 Other disorders of orbit	0.009	0.991	0.000
H01.0 Blepharitis	0.009	0.991	0.000
D04.1 Skin of eyelid, including canthus	0.000	0.991	0.009
D04.4 Skin of scalp and neck	0.000	0.991	0.009
D84.8 Other specified immunodeficiencies	0.008	0.991	0.000
H03.8 Involvement of eyelid in other diseases classified elsewhere	0.008	0.991	0.000
H03.0 Parasitic infestation of eyelid in diseases classified elsewhere	0.008	0.991	0.000
I51.4 Myocarditis, unspecified	0.000	0.992	0.008
D82.9 Immunodeficiency associated with major defect, unspecified	0.008	0.992	0.000
D82.8 Immunodeficiency associated with other specified major defects	0.008	0.992	0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.008	0.992	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.008	0.992	0.000
D82.2 Immunodeficiency with short-limbed stature	0.008	0.992	0.000
D82.0 Wiskott-Aldrich syndrome	0.008	0.992	0.000
H04.2 Epiphora	0.008	0.992	0.000
H03.1 Involvement of eyelid in other infectious diseases classified elsewhere	0.008	0.992	0.000
D04.8 Skin of other sites	0.000	0.993	0.007
D04.0 Skin of lip	0.000	0.993	0.007
D04.5 Skin of trunk	0.000	0.993	0.007
Z80.9 Family history of malignant neoplasm, unspecified	0.007	0.993	0.000
D04.6 Skin of upper limb, including shoulder	0.000	0.993	0.007
D82.1 Di George's syndrome	0.006	0.993	0.000
D04.2 Skin of ear and external auricular canal	0.000	0.993	0.006
I51.0 Cardiac septal defect, acquired	0.000	0.993	0.006
K26.4 Chronic or unspecified with haemorrhage	0.000	0.995	0.005
H00 Hordeolum and chalazion	0.005	0.995	0.000
K37 Unspecified appendicitis	0.005	0.995	0.000
M31.6 Other giant cell arteritis	0.004	0.996	0.000
H50.0 Convergent concomitant strabismus	0.000	0.996	0.004
T17.9 Foreign body in respiratory tract, part unspecified	0.000	0.996	0.004
H02 Other disorders of eyelid	0.004	0.996	0.000
H02.6 Xanthelasma of eyelid	0.004	0.996	0.000
E73.9 Lactose intolerance, unspecified	0.004	0.996	0.000
G25.8 Other specified extrapyramidal and movement disorders	0.000	0.996	0.004
H65.3 Chronic mucoid otitis media	0.000	0.997	0.003
Q44.6 Cystic disease of liver	0.000	0.997	0.003
O30.0 Twin pregnancy	0.003	0.997	0.000
I51.9 Heart disease, unspecified	0.000	0.997	0.003
H02.7 Other degenerative disorders of eyelid and periocular area	0.003	0.997	0.000
I47.1 Supraventricular tachycardia	0.000	0.997	0.003
Q50.4 Embryonic cyst of Fallopian tube	0.000	0.997	0.003
D89.2 Hypergammaglobulinaemia, unspecified	0.003	0.997	0.000
M24.27 Disorder of ligament (Ankle and foot)	0.000	0.997	0.003
T46.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes	0.003	0.997	0.000
F43.2 Adjustment disorders	0.003	0.997	0.000
H00.0 Hordeolum and other deep inflammation of eyelid	0.003	0.997	0.000
H50.9 Strabismus, unspecified	0.000	0.997	0.003
H73.8 Other specified disorders of tympanic membrane	0.003	0.997	0.000
C44.4 Skin of scalp and neck	0.000	0.997	0.003
H02.2 Lagophthalmos	0.003	0.997	0.000
Z37.2 Twins, both liveborn	0.003	0.997	0.000
J93 Pneumothorax	0.003	0.997	0.000
Z90.8 Acquired absence of other organs	0.003	0.997	0.000
O75.2 Pyrexia during labour, not elsewhere classified	0.003	0.997	0.000
H50.2 Vertical strabismus	0.000	0.997	0.003
H50 Other strabismus	0.000	0.997	0.003
Q44 Congenital malformations of gallbladder, bile ducts and liver	0.000	0.997	0.003
S06.40 Epidural haemorrhage (without open intracranial wound)	0.000	0.997	0.003
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.003	0.997	0.000
O75.7 Vaginal delivery following previous Caesarean section	0.003	0.997	0.000
O75 Other complications of labour and delivery, not elsewhere classified	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Z43.3 Attention to colostomy	0.003	0.997	0.000
I70.00 Atherosclerosis of aorta (without gangrene)	0.000	0.998	0.002
D52.9 Folate deficiency anaemia, unspecified	0.000	0.998	0.002
M24.2 Disorder of ligament	0.000	0.998	0.002
Q44.5 Other congenital malformations of bile ducts	0.000	0.998	0.002
Z43.0 Attention to tracheostomy	0.002	0.998	0.000
O75.3 Other infection during labour	0.002	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
X65.8 Other specified place	0.002	0.998	0.000
M21.47 Flat foot [pes planus] (acquired)-Ankle/foot	0.000	0.998	0.002
H50.6 Mechanical strabismus	0.000	0.998	0.002
H73.9 Disorder of tympanic membrane, unspecified	0.002	0.998	0.000
O75.8 Other specified complications of labour and delivery	0.002	0.998	0.000
Q44.4 Choledochal cyst	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
X78.0 Home	0.002	0.998	0.000
H11.8 Other specified disorders of conjunctiva	0.000	0.998	0.002
M24.26 Disorder of ligament (Lower leg)	0.000	0.998	0.002
S32.50 Fracture of pubis (closed)	0.002	0.998	0.000
M24.24 Disorder of ligament (Hand)	0.000	0.998	0.002
I45.6 Preexcitation syndrome	0.002	0.998	0.000
Z43.6 Attention to other artificial openings of urinary tract	0.002	0.998	0.000
J93.0 Spontaneous tension pneumothorax	0.002	0.998	0.000
Z43.4 Attention to other artificial openings of digestive tract	0.002	0.998	0.000
H50.8 Other specified strabismus	0.000	0.998	0.002
M24.21 Disorder of ligament (Shoulder region)	0.000	0.998	0.002
Z43 Attention to artificial openings	0.002	0.998	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.002	0.998	0.000
Q44.7 Other congenital malformations of liver	0.000	0.998	0.002
Q44.3 Congenital stenosis and stricture of bile ducts	0.000	0.998	0.002
Q44.2 Atresia of bile ducts	0.000	0.998	0.002
Q44.1 Other congenital malformations of gallbladder	0.000	0.998	0.002
Q44.0 Agenesis, aplasia and hypoplasia of gallbladder	0.000	0.998	0.002
T75.4 Effects of electric current	0.000	0.998	0.002
Z43.5 Attention to cyctostomy	0.002	0.998	0.000
J35 Chronic diseases of tonsils and adenoids	0.000	0.998	0.002
H50.3 Intermittent heterotropia	0.000	0.998	0.002
F32.0 Mild depressive episode	0.002	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
H50.5 Heterophoria	0.000	0.998	0.002
I61.9 Intracerebral haemorrhage, unspecified	0.002	0.998	0.000
O75.9 Complication of labour and delivery, unspecified	0.002	0.998	0.000
O75.4 Other complications of obstetric surgery and procedures	0.002	0.998	0.000
O75.1 Shock during or following labour and delivery	0.002	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.002	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
X65 Intentional self-poisoning by and exposure to alcohol	0.002	0.998	0.000
H02.3 Blepharochalasis	0.002	0.998	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
T46.7 Peripheral vasodilators	0.002	0.998	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
X78 Intentional self-harm by sharp object	0.002	0.998	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y88.3 Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient or of later complication, without mention of misadventure at the time of the procedure	0.002	0.998	0.000
Z03.3 Observation for suspected nervous system disorder	0.000	0.998	0.002
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.002	0.998	0.000
H54.9 Unspecified visual impairment (binocular)	0.002	0.998	0.000
M24.23 Disorder of ligament (Forearm)	0.000	0.998	0.002
N35.9 Urethral stricture, unspecified	0.000	0.998	0.002
H73 Other disorders of tympanic membrane	0.002	0.998	0.000
M24.29 Disorder of ligament (Site unspecified)	0.000	0.998	0.002
M24.25 Disorder of ligament (Pelvic region and thigh)	0.000	0.998	0.002
M24.22 Disorder of ligament (Upper arm)	0.000	0.998	0.002
M24.20 Disorder of ligament (Multiple sites)	0.000	0.998	0.002
O00.9 Ectopic pregnancy, unspecified	0.000	0.998	0.002
Q43.0 Meckel's diverticulum	0.000	0.998	0.002
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
M00.97 Pyogenic arthritis, unspecified (Ankle and foot)	0.000	0.998	0.002
T40.4 Other synthetic narcotics	0.002	0.998	0.000
O75.5 Delayed delivery after artificial rupture of membranes	0.002	0.998	0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
T45.4 Iron and its compounds	0.002	0.998	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
M24.28 Disorder of ligament (Other)	0.000	0.998	0.002
Z43.8 Attention to other artificial openings	0.002	0.998	0.000
Z88.4 Personal history of allergy to anaesthetic agent	0.002	0.998	0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.002	0.998	0.000
X60-X84 Intentional self-harm	0.002	0.998	0.000
G80.9 Infantile cerebral palsy, unspecified	0.000	0.998	0.002
G30.9 Alzheimer's disease, unspecified	0.002	0.998	0.000
X60.2 School, other institution and public administrative area	0.002	0.998	0.000
J35.3 Hypertrophy of tonsils with hypertrophy of adenoids	0.000	0.998	0.002
Z43.9 Attention to unspecified artificial opening	0.002	0.998	0.000
Z43.7 Attention to artificial vagina	0.002	0.998	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.002	0.998	0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
K38.1 Appendicular concretions	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
X62.9 Unspecified place	0.002	0.998	0.000
S22.00 Fracture of thoracic vertebra (closed)	0.000	0.998	0.002
T45.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Z29.2 Other prophylactic chemotherapy	0.002	0.998	0.000
E87.3 Alkalosis	0.002	0.998	0.000
H50.4 Other and unspecified heterotropia	0.000	0.998	0.002
X65.9 Unspecified place	0.002	0.998	0.000
X65.0 Home	0.002	0.998	0.000
X65.7 Farm	0.002	0.998	0.000
X65.6 Industrial and construction area	0.002	0.998	0.000
X65.5 Trade and service area	0.002	0.998	0.000
X65.4 Street and highway	0.002	0.998	0.000
X65.3 Sports and athletics area	0.002	0.998	0.000
X65.2 School, other institution and public administrative area	0.002	0.998	0.000
X65.1 Residential institution	0.002	0.998	0.000
X78.9 Unspecified place	0.002	0.998	0.000
X78.8 Other specified place	0.002	0.998	0.000
X78.7 Farm	0.002	0.998	0.000
X78.6 Industrial and construction area	0.002	0.998	0.000
X78.5 Trade and service area	0.002	0.998	0.000
X78.4 Street and highway	0.002	0.998	0.000
X78.3 Sports and athletics area	0.002	0.998	0.000
X78.2 School, other institution and public administrative area	0.002	0.998	0.000
X78.1 Residential institution	0.002	0.998	0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
X62.8 Other specified place	0.002	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
J93.9 Pneumothorax, unspecified	0.002	0.998	0.000
Z99.1 Dependence on respirator	0.002	0.998	0.000
H73.0 Acute myringitis	0.001	0.998	0.000
Q43 Other congenital malformations of intestine	0.000	0.998	0.002
Q43.9 Congenital malformation of intestine, unspecified	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.002	0.998	0.000
T86.0 Bone-marrow transplant rejection	0.002	0.998	0.000
Z43.1 Attention to gastrostomy	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.002	0.998	0.000
S66.7 Injury of multiple extensor muscles and tendons at wrist and hand level	0.002	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
Z99.3 Dependence on wheelchair	0.002	0.998	0.000
X83 Intentional self-harm by other specified means	0.002	0.998	0.000
E73 Lactose intolerance	0.002	0.998	0.000
H65 Nonsuppurative otitis media	0.000	0.998	0.002
S52.10 Fracture of upper end of radius (closed)	0.000	0.998	0.002
H72.9 Perforation of tympanic membrane, unspecified	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.001	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.001	0.998	0.000
T44.0 Anticholinesterase agents	0.001	0.998	0.000
X60.5 Trade and service area	0.002	0.998	0.000
X84 Intentional self-harm by unspecified means	0.002	0.998	0.000
D58.0 Hereditary spherocytosis	0.002	0.998	0.000
Q50.5 Embryonic cyst of broad ligament	0.000	0.998	0.001
T47.0 Histamine H(2)-receptor antagonists	0.002	0.998	0.000
X62.0 Home	0.001	0.998	0.000
X62.7 Farm	0.001	0.998	0.000
X62.6 Industrial and construction area	0.001	0.998	0.000
X62.5 Trade and service area	0.001	0.998	0.000
X62.4 Street and highway	0.001	0.998	0.000
X62.3 Sports and athletics area	0.001	0.998	0.000
X62.2 School, other institution and public administrative area	0.001	0.998	0.000
X62.1 Residential institution	0.001	0.998	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.002	0.998	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.002	0.998	0.000
X80 Intentional self-harm by jumping from a high place	0.002	0.998	0.000
X79 Intentional self-harm by blunt object	0.002	0.998	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.002	0.998	0.000
X76 Intentional self-harm by smoke, fire and flames	0.002	0.998	0.000
X75 Intentional self-harm by explosive material	0.002	0.998	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.002	0.998	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.002	0.998	0.000
X72 Intentional self-harm by handgun discharge	0.002	0.998	0.000
X71 Intentional self-harm by drowning and submersion	0.002	0.998	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.002	0.998	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.002	0.998	0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
G11.9 Hereditary ataxia, unspecified	0.000	0.998	0.002
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.002	0.998	0.000
J93.8 Other pneumothorax	0.001	0.998	0.000
O71.4 Obstetric high vaginal laceration alone	0.000	0.998	0.002
T40.6 Other and unspecified narcotics	0.002	0.998	0.000
T46.1 Calcium-channel blockers	0.001	0.998	0.000
Z94.8 Other transplanted organ and tissue status	0.002	0.998	0.000
C67.9 Bladder, unspecified	0.002	0.998	0.000
H73.1 Chronic myringitis	0.001	0.998	0.000
K08.3 Retained dental root	0.002	0.998	0.000
Q76.4 Other congenital malformations of spine, not associated with scoliosis	0.002	0.998	0.000
T36.3 Macrolides	0.001	0.998	0.000
T40.3 Methadone	0.002	0.998	0.000
T45.5 Anticoagulants	0.001	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.998	0.000
T47.7 Emetics	0.001	0.998	0.000
T47.5 Digestants	0.001	0.998	0.000
T47.4 Other laxatives	0.001	0.998	0.000
T47.3 Saline and osmotic laxatives	0.001	0.998	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.001	0.998	0.000
N18.2 Chronic kidney disease, stage 2	0.000	0.998	0.002
Q43.3 Congenital malformations of intestinal fixation	0.000	0.998	0.001
R82.8 Abnormal findings on cytological and histological examination of urine	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.001	0.998	0.000
X60.9 Unspecified place	0.001	0.998	0.000
X60.0 Home	0.001	0.998	0.000
X60.7 Farm	0.001	0.998	0.000
X60.6 Industrial and construction area	0.001	0.998	0.000
X60.4 Street and highway	0.001	0.998	0.000
X60.3 Sports and athletics area	0.001	0.998	0.000
X60.1 Residential institution	0.001	0.998	0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.001	0.998	0.000
Z82.5 Family history of asthma and other chronic lower respiratory diseases	0.000	0.998	0.002
Q40 Other congenital malformations of upper alimentary tract	0.000	0.998	0.002
X68 Intentional self-poisoning by and exposure to pesticides	0.001	0.998	0.000
X65.09 Intentional self-poisoning by and exposure to alcohol, Home, During unspecified activity	0.001	0.998	0.000
X65.99 Intentional self-poisoning by and exposure to alcohol, Unspecified place, During unspecified activity	0.001	0.998	0.000
X65.98 Intentional self-poisoning by and exposure to alcohol; Unspecified place ;While engaged in other specified activities	0.001	0.998	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.001	0.998	0.000
X78.99 Intentional self-harm by sharp object: Unspecified place: During unspecified activity	0.001	0.998	0.000
J35.2 Hypertrophy of adenoids	0.000	0.998	0.001
O75.0 Maternal distress during labour and delivery	0.001	0.998	0.000
Q50.6 Other congenital malformatons of Fallopian tube and broad ligament	0.000	0.998	0.001
Q50.3 Other congenital malformations of ovary	0.000	0.998	0.001
Q50.2 Congenital torsion of ovary	0.000	0.998	0.001
Q50.1 Developmental ovarian cyst	0.000	0.998	0.001
Q50.0 Congenital absence of ovary	0.000	0.998	0.001
S06.4 Epidural haemorrhage	0.000	0.998	0.001
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.001	0.998	0.000
C67.6 Ureteric orifice	0.002	0.998	0.000
O00.1 Tubal pregnancy	0.000	0.998	0.002
Q40.2 Other specified congenital malformations of stomach	0.000	0.998	0.001
S49.9 Unspecified injury of shoulder and upper arm	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.001	0.998	0.000
T40.8 Lysergide [LSD]	0.001	0.998	0.000
T40.7 Cannabis (derivatives)	0.001	0.998	0.000
T40.0 Opium	0.001	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.001	0.998	0.000
X83.9 Unspecified place	0.001	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.001	0.998	0.000
H11.3 Conjunctival haemorrhage	0.001	0.998	0.000
H65.1 Other acute nonsuppurative otitis media	0.000	0.998	0.001
J35.9 Chronic disease of tonsils and adenoids, unspecified	0.000	0.998	0.001
M00.9 Pyogenic arthritis, unspecified	0.000	0.998	0.002
Q43.7 Persistent cloaca	0.000	0.998	0.001
Q43.6 Congenital fistula of rectum and anus	0.000	0.998	0.001
Q43.5 Ectopic anus	0.000	0.998	0.001
Q43.4 Duplication of intestine	0.000	0.998	0.001
Q43.2 Other congenital functional disorders of colon	0.000	0.998	0.001
T36.9 Systemic antibiotic, unspecified	0.001	0.998	0.000
T36.8 Other systemic antibiotics	0.001	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.001	0.998	0.000
T36.6 Rifamycins	0.001	0.998	0.000
T36.5 Aminoglycosides	0.001	0.998	0.000
T36.2 Chloramphenicol group	0.001	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.001	0.998	0.000
T40.5 Cocaine	0.001	0.998	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.001	0.998	0.000
Q38-Q45 Other congenital malformations of the digestive system	0.000	0.998	0.002
M00.93 Pyogenic arthritis, unspecified (Forearm)	0.000	0.998	0.001
M00.90 Pyogenic arthritis, unspecified (Multiple sites)	0.000	0.998	0.001
T49.9 Topical agent, unspecified	0.001	0.998	0.000
T49.8 Other topical agents	0.001	0.998	0.000
T49.7 Dental drugs, topically applied	0.001	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.001	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.001	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.001	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.001	0.998	0.000
T49.2 Local astringents and local detergents	0.001	0.998	0.000
T49.1 Antipruritics	0.001	0.998	0.000
X61.4 Street and highway	0.001	0.998	0.000
M21.37 Wrist or foot drop (acquired) (Ankle and foot)	0.001	0.999	0.000
Q40.3 Congenital malformation of stomach, unspecified	0.000	0.999	0.001
R06.5 Mouth breathing	0.000	0.999	0.001
T38.0 Glucocorticoids and synthetic analogues	0.001	0.999	0.000
T47.2 Stimulant laxatives	0.001	0.999	0.000
X83.8 Other specified place	0.001	0.999	0.000
X83.7 Farm	0.001	0.999	0.000
X83.6 Industrial and construction area	0.001	0.999	0.000
X83.5 Trade and service area	0.001	0.999	0.000
X83.4 Street and highway	0.001	0.999	0.000
X83.3 Sports and athletics area	0.001	0.999	0.000
X83.2 School, other institution and public administrative area	0.001	0.999	0.000
X83.1 Residential institution	0.001	0.999	0.000
X83.0 Home	0.001	0.999	0.000
E73.8 Other lactose intolerance	0.001	0.999	0.000
E73.1 Secondary lactase deficiency	0.001	0.999	0.000
E73.0 Congenital lactase deficiency	0.001	0.999	0.000
G80.8 Other infantile cerebral palsy	0.000	0.999	0.001
H65.9 Nonsuppurative otitis media, unspecified	0.000	0.999	0.001
X84.8 Other specified place	0.001	0.999	0.000
X84.7 Farm	0.001	0.999	0.000
X84.6 Industrial and construction area	0.001	0.999	0.000
X84.5 Trade and service area	0.001	0.999	0.000
X84.4 Street and highway	0.001	0.999	0.000
X84.3 Sports and athletics area	0.001	0.999	0.000
X84.2 School, other institution and public administrative area	0.001	0.999	0.000
X84.1 Residential institution	0.001	0.999	0.000
X84.0 Home	0.001	0.999	0.000
Z99.9 Dependence on unspecified enabling machine and device	0.001	0.999	0.000
T17 Foreign body in respiratory tract	0.000	0.999	0.001
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity	0.001	0.999	0.000
H26.4 After-cataract	0.001	0.999	0.000
H65.4 Other chronic nonsuppurative otitis media	0.000	0.999	0.001
X60.8 Other specified place	0.001	0.999	0.000
X61.9 Unspecified place	0.001	0.999	0.000
X61.8 Other specified place	0.001	0.999	0.000
X61.0 Home	0.001	0.999	0.000
X61.7 Farm	0.001	0.999	0.000
X61.6 Industrial and construction area	0.001	0.999	0.000
X61.5 Trade and service area	0.001	0.999	0.000
X61.3 Sports and athletics area	0.001	0.999	0.000
X61.1 Residential institution	0.001	0.999	0.000
X64.9 Unspecified place	0.001	0.999	0.000
X64.0 Home	0.001	0.999	0.000
X64.8 Other specified place	0.001	0.999	0.000
X64.7 Farm	0.001	0.999	0.000
X64.6 Industrial and construction area	0.001	0.999	0.000
X64.5 Trade and service area	0.001	0.999	0.000
X64.4 Street and highway	0.001	0.999	0.000
X64.3 Sports and athletics area	0.001	0.999	0.000
X64.2 School, other institution and public administrative area	0.001	0.999	0.000
X64.1 Residential institution	0.001	0.999	0.000
X66.9 Unspecified place	0.001	0.999	0.000
X66.8 Other specified place	0.001	0.999	0.000
X66.7 Farm	0.001	0.999	0.000
X66.6 Industrial and construction area	0.001	0.999	0.000
X66.5 Trade and service area	0.001	0.999	0.000
X66.4 Street and highway	0.001	0.999	0.000
X66.3 Sports and athletics area	0.001	0.999	0.000
X66.2 School, other institution and public administrative area	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations